Comparison of viral shedding following vaccination with inactivated and live newcastle disease vaccines formulated with wild-type and recombinant viruses

Avian Diseases

Volumn 53, Issue 1, 2009, Pages 39-49

  Miller, Patti J ^a   Estevez, Carlos ^a   Yu, Qingzhong ^a   Suarez, David L ^a   King, Daniel J ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

APMV 1; NDV; Newcastle disease; Poultry; Vaccine

Indexed keywords

VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ARTICLE; BIRD DISEASE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GERMFREE ANIMAL; IMMUNOLOGY; NEWCASTLE DISEASE PARAMYXOVIRUS; PHYSIOLOGY; VACCINATION; VIROLOGY; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VIRAL VACCINES; VIRUS SHEDDING;

AVES; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 63449102132     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8407-071208-Reg.1     Document Type: Article

References (36)

1. Alexander, D. J. Newcastle disease virus and other avian paramyxo- vίruses. In; A laboratory manual for the isolation and identification of avian pathogens, 4th ed. D. E. Swayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, and W. M. Reed, eds. American Association of Avian Pathologists, Kennett Square, PA. pp. 156-163. 1998.
2. Alexander, D. J. Newcastle disease, other avian paramyxoviruses, and pneumovirus infections. In: Diseases of poultry, 11th ed. Y. M. Saif, H. J. Barnes, J. R. Glisson, A. M. Fadly, L. R. McDougald, and D. E. Swayne, eds. Iowa State University Press, Ames, IA. pp. 63-87. 2003.
3. Avery, R. J., and J. Niven. Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations. Infect. Immun. 26:795-801. 1979.
4. Boursnell, M. E., P. F. Green, J. I. Campbell, A. Deuter, R. W. Peters, F. M. Tornley, A. C. Samson, P. Chambers, P. T. Emmerson, and M. M. Binns. Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recornbinant. J. Gen. Virol. 71 (Pt 3):621-628. 1990.
5. Boursnell, M. E., P. F. Green, J. I. Campbell, A. Deuter, R. W. Peters, F. M. Tomley, A. C. Samson, P. T. Emmerson, and M. M. Binns. A fowlpox virus vaccine vector with insertion sites in the terminal repeats: demonstration of its efficacy using the fusion gene of Newcastle disease virus. Vet. Microbiol. 23:305-316. 1990.
6. Boursnell, M. E., P. F. Green, A. C. Samson, J. I. Campbell, A. Deuter, R. W. Peters, N. S. Millar, P. T. Emmerson, and M. M. Binns. A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 178:297-300. 1990.
7. Brown, C, D. J. King, and B. S. Seal. Pathogenesis of Newcasde disease in chickens experimentally infected with viruses of different virulence. Vet. Pathol. 36:125-132. 1999.
8. Budowsky, E. L, A. Smirnov Yu, and S. F. Shenderovich. Principles of selective Inactivation of viral genome. VIII. The influence of beta- propiolactone on immunogenic and protective activities of influenza virus. Vaccine 11:343-348. 1993.
9. Edbauer, C, R. Weinberg, J. Taylor, A. Rey-Senelonge, J. F. Bouquet, P. Desmettre, and E. Paoletti. Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemag- glutinin-neuraminidase gene. Virology 179:901-904. 1990.
10. Estevez, C, D. King, B. Seal, and Q. Yu. Evaluation of Newcasde disease virus chimeras expressing the hemagglutinin-neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone. Virus Res. 129:182-190. 2007.
11. Fauquet, C. M., and D. Fargette. International Committee on Taxonomy of Viruses and the 3,142 unassigned species. Virol. J. 2:64. 2005.
12. Jayawardane, G. W., and P. B. Spradbrow. Cell-mediated immunity in chickens vaccinated with the V4 strain of Newcastle disease virus. Vet. Microbiol. 46:37-41. 1995.
13. Jayawardane, G. W., and P. B. Spradbrow. Mucosal immunity in chickens vaccinated with the V4 strain of Newcastle disease virus. Vet. Microbiol. 46:69-77. 1995.
14. Kamiya, N., M. Niikura, M. Ono, C. Kai, Y. Matsuura, and T. Mikami. Protective effect of individual glycoproteins of Newcasde disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy. Virus Res. 32:373-379. 1994.
15. Kapczynski, D. R., and D. J. King. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcasde disease outbreak. Vaccine 23:3424-3433. 2005.
16. Karber, G. 50% end-point calculation. Arch. Exp. Pathol. Pharmak. 162:480-483. 1931.
17. King, D. J. Influence of chicken breed on pathogenicity evaluation of velogenic neurotropic Newcasde disease virus isolates from cormorants and turkeys. Avian Dis. 40:210-217. 1996.
18. King, D. J., and B. S. Seal. Biological and molecular characterization of Newcasde disease virus (NDV) field isolates with comparisons to reference NDV strains. Avian Dis. 42:507-516. 1998.
19. Loke, C. F., A. R. Omar, A. R. Raha, and K. Yusoff. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet. Immunol. Immunopathol. 106:259-267. 2005.
20. Long, L., D. Portetelle, J. Ghysdael, M. Gonze, A. Burny, and G. Meulemans. Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity. J. Virol. 57:1198-1202. 1986.
21. Mayo, M. A. A summary of taxonomic changes recently approved by ICTV. Arch. Virol. 147:1655-1663. 2002.
22. Merz, D. O, A. Scheid, and P. W. Choppin. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J. Exp. Med. 151:275-288. 1980.
23. Miller, P. J., D. J. King, C. L. Afonso, and D. L. Suarez. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25:7238-7246. 2007.
24. Nakaya, T., J. Cros, M. S. Park, Y. Nakaya, H. Zheng, A. Sagrera, E. Villar, A. Garcia-Sastre, and P. Palese. Recombinant Newcasde disease virus as a vaccine vector. J. Virol. 75:11868-11873. 2001.
25. Nolan, R. Exotic Newcasde disease strikes game birds in California. J. Am. Vet. Med. Assoc. 10:1369-1370. 2002.
26. Park, M. S., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U. S. A. 103:8203-8208. 2006.
27. Pedersen, J. C, D. A. Senne, P. R. Woolcock, H. Kinde, D. J. King, M. G. Wise, B. Panigrahy, and B. S. Seal. Phylogenetic relationships among virulent Newcasde disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America. J. Clin. Microbiol. 42:2329-2334. 2004.
28. Spradbrow, P. B., and J. L. Samuel. Oral Newcastle disease vaccination with V4 virus in chickens: comparison with other routes. Aust. Vet. J. 68:114-115. 1991.
29. Stone, H. D., M. Brugh, and C. W. Beard. Influence of formulation on the efficacy of experimental oil-emulsion Newcastle disease vaccines. Avian Dis. 27:688-697. 1983.
30. Stone, H. D., M. Brugh, S. R. Hopkins, H. W. Yoder, and C. W. Beard. Preparation of inactivated oil-emulsion vaccines with avian viral or Mycoplasma antigens. Avian Dis. 22:666-674. 1978.
31. Suarez, D. L., C. W. Lee, and D. E. Swayne. Avian influenza vaccination in North America: strategies and difficulties. Dev. Biol. (Basel) 124:117-124. 2006.
32. Taylor, J., C. Edbauer, A. Rey-Senelonge, J. F. Bouquet, E. Norton, S. Goebel, P. Desmettre, and E. Paoletti. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 64:1441-1450. 1990.
33. Thayer, S. G., and C. W. Beard. Serological procedures. In: A laboratory manual for the isolation and identification of avian pathogens, 4th ed. D. E. Swayne, ed. American Association of Avian Pathologists, Kennett Square, PA. pp. 255-266. 1998.
34. Umino, Y., T. Kohama, M. Kohase, A. Sugiura, H. D. Klenk, and R. Rott. Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus. Arch. Virol. 81:53-65. 1984.
35. van Boven, M., A. Bouma, T. H. Fabri, E. Katsma, L. Hartog, and G. Koch. Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol. 37:1-5. 2008.
36. Wakamatsu, N., D. J. King, D. R. Kapczynski, B. S. Seal, and C. C. Brown. Experimental pathogenesis for chickens, turkeys, and pigeons of exotic Newcasde disease virus from an outbreak in California during 2002- 2003. Vet. Pathol. 43:925-933. 2006.